Biobanking Equipment Market - Size, Share, Trends,
Outlook, and Opportunity Analysis, 2018-2026
Biobanking is referred to a structured collections of biological samples, and associated data,
stored for research purpose in future. The biobanks typically handle human biospecimens such
as blood, tissue, and urine. They are established within academic medical or research
institutions, pharmaceuticals or biotechnological companies or as a standalone organizations.
Biobanks can be disease-oriented or population-based and they can contain a variety of samples
such as blood, enzymes, organ tissue, urine, DNA, RNA, and cell lines.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2365
Increasing awareness and adoption of precision medicine are expected to favor the biobanking
equipment market growth
Increase in research and development in molecular biology and precision medicine is also
expected to favor growth of the biobanking equipment market. In 2014, the Biobanking and
BioMolecular resources Research Infrastructure–European Research Infrastructure Consortium
(BBMRIERIC), an organization for biobanking in Europe, was established to provide a focal
point for biobanking activities in Europe. It also provides access to quality-controlled human
biological samples and associated data for cross-biobanking research.
The biobanks also play a critical role in cancer research, as they provide access to the status of
human genome. The complex networks of interactions between biomolecules and the clinical
and functional consequences of their alteration can be studied on human genome instead of
human biological specimens, which is easy for discovering new mechanisms involved in cancer.
Biobanks are rapidly expanding in biomedical science domains including molecular pathology,
molecular and genetic epidemiology, and pharmacogenomics.